SCHEMBL22906154

SCHEMBL22906154

CCOC(=O)c1c(C)c(C(=O)C(=O)OC)n(C)c1Cl

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.51
USP2 O75604 1/20 0.49
HPGD P15428 4/20 0.42
THRB P10828 1/20 0.42
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
TSHR P16473 1/20 0.39
CYP2C19 P33261 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
ALDH1A1 P00352 3/20 0.39
KDM4E B2RXH2 1/20 0.39
MAPT P10636 3/20 0.38
MAPK1 P28482 2/20 0.38
KCNH2 Q12809 1/20 0.38
MEN1 O00255 1/20 0.38
SHMT2 P34897 1/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21427861 0.91 KMT2A (0.54) KMT2AUSP2HPGDTHRBCYP1A2
SCHEMBL21427864 0.85 USP2 (0.55) KMT2AUSP2HPGDTHRBCYP1A2
SCHEMBL21428269 0.83 KMT2A (0.49) KMT2AUSP2HPGDTHRBCYP1A2
SCHEMBL25645222 0.81 KMT2A (0.47) KMT2AUSP2HPGDTHRBCYP1A2
SCHEMBL22906168 0.76 KMT2A (0.42) KMT2AUSP2HPGDTHRBCYP1A2
SCHEMBL22906153 0.76 KMT2A (0.42) KMT2AUSP2HPGDTHRBCYP1A2
SCHEMBL28497756 0.76 KMT2A (0.42) KMT2AUSP2HPGDTHRBCYP1A2
SCHEMBL21408305 0.76 KMT2A (0.76) KMT2AUSP2HPGDTHRBCYP1A2
SCHEMBL28898144 0.76 KMT2A (0.41) KMT2AUSP2HPGDTHRBCYP1A2
SCHEMBL23499028 0.74 KMT2A (0.54) KMT2AUSP2HPGDTHRBCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230183208-A1 N-HETEROCYCLIC FIVE-MEMBERED RING-CONTAINING CAPSID PROTEIN ASSEMBLY INHIBITOR, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. (CN) 2023-06-15 US disclosed
US-20210017154-A1 N-HETEROCYCLIC FIVE-MEMBERED RING-CONTAINING CAPSID PROTEIN ASSEMBLY INHIBITOR, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD. (CN) 2021-01-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230183208-A1 N-HETEROCYCLIC FIVE-MEMBERED RING-CONTAINING CAPSID PROTEIN ASSEMBLY INHIBITOR, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF COG5, HAVCR2, ZC3HAV1 KMT2A 4197/4885USP2 1858/4885HPGD 729/4885
US-20210017154-A1 N-HETEROCYCLIC FIVE-MEMBERED RING-CONTAINING CAPSID PROTEIN ASSEMBLY INHIBITOR, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF COG5, HAVCR2, ZC3HAV1 KMT2A 4197/4885USP2 1858/4885HPGD 729/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.